Logo image of TEAM

ATLASSIAN CORP-CL A (TEAM) Stock Fundamental Analysis

NASDAQ:TEAM - Nasdaq - US0494681010 - Common Stock - Currency: USD

208.48  -20.59 (-8.99%)

After market: 209.01 +0.53 (+0.25%)

Fundamental Rating

4

Overall TEAM gets a fundamental rating of 4 out of 10. We evaluated TEAM against 281 industry peers in the Software industry. TEAM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TEAM is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

TEAM had positive earnings in the past year.
TEAM had a positive operating cash flow in the past year.
In the past 5 years TEAM always reported negative net income.
In the past 5 years TEAM always reported a positive cash flow from operatings.
TEAM Yearly Net Income VS EBIT VS OCF VS FCFTEAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

TEAM has a Return On Assets of -6.36%. This is comparable to the rest of the industry: TEAM outperforms 44.13% of its industry peers.
With a Return On Equity value of -28.38%, TEAM perfoms like the industry average, outperforming 40.21% of the companies in the same industry.
Industry RankSector Rank
ROA -6.36%
ROE -28.38%
ROIC N/A
ROA(3y)-11.08%
ROA(5y)-12.38%
ROE(3y)-87.38%
ROE(5y)-103.88%
ROIC(3y)N/A
ROIC(5y)N/A
TEAM Yearly ROA, ROE, ROICTEAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

TEAM's Gross Margin of 81.82% is amongst the best of the industry. TEAM outperforms 86.83% of its industry peers.
In the last couple of years the Gross Margin of TEAM has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for TEAM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5Y-0.26%
TEAM Yearly Profit, Operating, Gross MarginsTEAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

TEAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TEAM has more shares outstanding
TEAM has more shares outstanding than it did 5 years ago.
The debt/assets ratio for TEAM has been reduced compared to a year ago.
TEAM Yearly Shares OutstandingTEAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
TEAM Yearly Total Debt VS Total AssetsTEAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 8.53 indicates that TEAM is not in any danger for bankruptcy at the moment.
The Altman-Z score of TEAM (8.53) is better than 83.63% of its industry peers.
The Debt to FCF ratio of TEAM is 0.71, which is an excellent value as it means it would take TEAM, only 0.71 years of fcf income to pay off all of its debts.
TEAM's Debt to FCF ratio of 0.71 is fine compared to the rest of the industry. TEAM outperforms 74.73% of its industry peers.
A Debt/Equity ratio of 0.81 indicates that TEAM is somewhat dependend on debt financing.
TEAM has a worse Debt to Equity ratio (0.81) than 72.24% of its industry peers.
Even though the debt/equity ratio score it not favorable for TEAM, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 0.71
Altman-Z 8.53
ROIC/WACCN/A
WACC10.67%
TEAM Yearly LT Debt VS Equity VS FCFTEAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.3 Liquidity

TEAM has a Current Ratio of 1.24. This is a normal value and indicates that TEAM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of TEAM (1.24) is worse than 62.99% of its industry peers.
TEAM has a Quick Ratio of 1.24. This is a normal value and indicates that TEAM is financially healthy and should not expect problems in meeting its short term obligations.
TEAM has a worse Quick ratio (1.24) than 62.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 1.24
TEAM Yearly Current Assets VS Current LiabilitesTEAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

8

3. Growth

3.1 Past

TEAM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.31%, which is quite good.
TEAM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 27.78% yearly.
Looking at the last year, TEAM shows a very strong growth in Revenue. The Revenue has grown by 23.31%.
TEAM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.21% yearly.
EPS 1Y (TTM)18.31%
EPS 3Y28.22%
EPS 5Y27.78%
EPS Q2Q%8.99%
Revenue 1Y (TTM)23.31%
Revenue growth 3Y27.78%
Revenue growth 5Y29.21%
Sales Q2Q%14.09%

3.2 Future

Based on estimates for the next years, TEAM will show a very strong growth in Earnings Per Share. The EPS will grow by 22.16% on average per year.
TEAM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.54% yearly.
EPS Next Y22.5%
EPS Next 2Y22.23%
EPS Next 3Y22.46%
EPS Next 5Y22.16%
Revenue Next Year18.95%
Revenue Next 2Y19.4%
Revenue Next 3Y19.47%
Revenue Next 5Y18.54%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TEAM Yearly Revenue VS EstimatesTEAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
TEAM Yearly EPS VS EstimatesTEAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

TEAM is valuated quite expensively with a Price/Earnings ratio of 62.05.
TEAM's Price/Earnings is on the same level as the industry average.
TEAM is valuated expensively when we compare the Price/Earnings ratio to 28.22, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 47.63, the valuation of TEAM can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as TEAM.
When comparing the Price/Forward Earnings ratio of TEAM to the average of the S&P500 Index (20.86), we can say TEAM is valued expensively.
Industry RankSector Rank
PE 62.05
Fwd PE 47.63
TEAM Price Earnings VS Forward Price EarningsTEAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

62.28% of the companies in the same industry are more expensive than TEAM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 39.45
EV/EBITDA N/A
TEAM Per share dataTEAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TEAM does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as TEAM's earnings are expected to grow with 22.46% in the coming years.
PEG (NY)2.76
PEG (5Y)2.23
EPS Next 2Y22.23%
EPS Next 3Y22.46%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TEAM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATLASSIAN CORP-CL A

NASDAQ:TEAM (5/2/2025, 8:25:15 PM)

After market: 209.01 +0.53 (+0.25%)

208.48

-20.59 (-8.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)08-01 2025-08-01/amc
Inst Owners94.17%
Inst Owner Change0.61%
Ins Owners0.3%
Ins Owner Change-0.02%
Market Cap54.62B
Analysts80
Price Target310.72 (49.04%)
Short Float %3.41%
Short Ratio2.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.78%
Min EPS beat(2)17.19%
Max EPS beat(2)24.37%
EPS beat(4)4
Avg EPS beat(4)22.08%
Min EPS beat(4)6.96%
Max EPS beat(4)39.79%
EPS beat(8)8
Avg EPS beat(8)25.11%
EPS beat(12)10
Avg EPS beat(12)22.99%
EPS beat(16)14
Avg EPS beat(16)25.58%
Revenue beat(2)2
Avg Revenue beat(2)1.26%
Min Revenue beat(2)0.83%
Max Revenue beat(2)1.7%
Revenue beat(4)3
Avg Revenue beat(4)1.73%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)6.27%
Revenue beat(8)5
Avg Revenue beat(8)0.99%
Revenue beat(12)8
Avg Revenue beat(12)1.1%
Revenue beat(16)12
Avg Revenue beat(16)1.94%
PT rev (1m)-12.88%
PT rev (3m)13.83%
EPS NQ rev (1m)-0.16%
EPS NQ rev (3m)6.65%
EPS NY rev (1m)-0.12%
EPS NY rev (3m)7.29%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)2.84%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)1.36%
Valuation
Industry RankSector Rank
PE 62.05
Fwd PE 47.63
P/S 11.39
P/FCF 39.45
P/OCF 38.36
P/B 44.79
P/tB N/A
EV/EBITDA N/A
EPS(TTM)3.36
EY1.61%
EPS(NY)4.38
Fwd EY2.1%
FCF(TTM)5.28
FCFY2.53%
OCF(TTM)5.44
OCFY2.61%
SpS18.3
BVpS4.65
TBVpS-1.32
PEG (NY)2.76
PEG (5Y)2.23
Profitability
Industry RankSector Rank
ROA -6.36%
ROE -28.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.82%
FCFM 28.87%
ROA(3y)-11.08%
ROA(5y)-12.38%
ROE(3y)-87.38%
ROE(5y)-103.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5Y-0.26%
F-Score7
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 0.71
Debt/EBITDA N/A
Cap/Depr 42.75%
Cap/Sales 0.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 1.24
Altman-Z 8.53
F-Score7
WACC10.67%
ROIC/WACCN/A
Cap/Depr(3y)76.2%
Cap/Depr(5y)64.97%
Cap/Sales(3y)1.38%
Cap/Sales(5y)1.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.31%
EPS 3Y28.22%
EPS 5Y27.78%
EPS Q2Q%8.99%
EPS Next Y22.5%
EPS Next 2Y22.23%
EPS Next 3Y22.46%
EPS Next 5Y22.16%
Revenue 1Y (TTM)23.31%
Revenue growth 3Y27.78%
Revenue growth 5Y29.21%
Sales Q2Q%14.09%
Revenue Next Year18.95%
Revenue Next 2Y19.4%
Revenue Next 3Y19.47%
Revenue Next 5Y18.54%
EBIT growth 1Y24.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.45%
EBIT Next 3Y26.26%
EBIT Next 5Y21.79%
FCF growth 1Y93.12%
FCF growth 3Y23.2%
FCF growth 5Y27.5%
OCF growth 1Y79.67%
OCF growth 3Y22.39%
OCF growth 5Y25.44%